Crossmark

Genes-first and phenotypes-first paths to treatment resistance in hematological malignancies

Published Online: 2025-11-10

Authors

Tamellini, Edoardo

Frusteri, Cristina

Ferrarini, Isacco https://orcid.org/0000-0001-9867-8335
License Information

Text and Data Mining valid from 2025-11-10

Version of Record valid from 2025-11-10
More Information

Article History

Received: 9 January 2025

Revised: 10 September 2025

Accepted: 7 October 2025

First Online: 10 November 2025

Competing interests

: I.F. received research funding from AbbVie, BeiGene, and Eli-Lilly. The other authors declare no conflict of interest.

Document is current